Evacal D3 1500mg/400iu Chewable Tablets - metal contamination in a very small number of tablets
(Teva UK Limited) Precautionary batch recall of Evacal D3 1500mg/400iu Chewable Tablets after metal contamination was identified in a very small number of tablets
Product information
EL number
EL (16)A/16
MDR number
MDR 100-11/16
Company name
TEVA UK Limited
Product description
Evacal D3 1500mg/400iu Chewable Tablets (calcium carbonate / colecalciferol)
PL 0289/1742
Batch number/expiry
Pack size 1 x 56
Batch no | Expiry date | First distributed |
---|---|---|
6010615 | Dec 2017 | 15 Jul 2016 |
6010616 | Dec 2017 | 13 Jul 2016 |
6010617 | Dec 2017 | 12 Jul 2016 |
6010618 | Dec 2017 | 19 Jul 2016 |
6010619 | Dec 2017 | 07 Jul 2016 |
6010620 | Dec 2017 | 11 Aug 2016 |
6010621 | Dec 2017 | 29 Jul 2016 |
6010622 | Dec 2017 | 10 Aug 2016 |
Pack size 1 x 112
Batch no | Expiry date | First distributed |
---|---|---|
6011671 | Dec 2017 | 02 Mar 2016 |
6011673 | Dec 2017 | 14 Mar 2016 |
6011674 | Dec 2017 | 04 Mar 2016 |
6011675 | Dec 2017 | 16 Jun 2016 |
6011676 | Dec 2017 | 08 Jun 2016 |
Brief description of the problem
Teva UK Limited is recalling the above batches as a precaution because metal contamination has been identified in a very small number of tablets. All the listed batches were manufactured using the same batch of active pharmaceutical ingredient, which is believed to be the source of the contamination.
Remaining stock of these batches should be quarantined and returned to the original supplier for credit.
Company details
For stock enquiries, please contact Teva UK Limited Customer Service on 0800 590 502
For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email to medinfo@teva.com.
Download document
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS Regional teams: please cascade to relevant clinics, general practitioners and community pharmacists.